Literature DB >> 12838188

Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

Don S Lee1, Marjorie A Rosenberg, Andrew Peterson, Linda Makholm, Gary Hoffman, Ronald H Laessig, Philip M Farrell.   

Abstract

OBJECTIVES: To compare the cost of diagnosing cystic fibrosis (CF) through a newborn screening program with the traditional method and to estimate the cost of CF diagnosis if a national newborn screening program is implemented. STUDY
DESIGN: Surveys were conducted to determine the annual number of sweat tests in 1991 and in 2000 after implementation of statewide screening. A national survey of sweat test costs was used to estimate the annual expense for diagnosing CF in the United States through newborn screening.
RESULTS: Since the introduction of newborn screening for CF, the numbers of sweat tests ordered annually have decreased from 1670 to 804 (including 134 follow-up tests from screening). The current estimated annual cost of Wisconsin CF newborn screening and diagnosis is $4.58 per newborn infant. The estimated annual cost per newly diagnosed CF infant using the traditional method is $4.97 per newborn infant. If no additional sweat tests were ordered outside of the newborn screening program, the estimated annual cost of a Wisconsin CF newborn screening and diagnosis is $2.66 per newborn and $2.47 per newborn for a national CF newborn screening program.
CONCLUSIONS: A CF newborn screening program provides a potentially cost-saving alternative to the traditional method of diagnosis of CF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838188     DOI: 10.1067/mpd.2003.209

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

2.  Neonatal screening: from the 'Guthrie age' to the 'genetic age'.

Authors:  Jean-Louis Dhondt
Journal:  J Inherit Metab Dis       Date:  2007-05-12       Impact factor: 4.982

3.  Newborn screening for cystic fibrosis: techniques and strategies.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2007-05-12       Impact factor: 4.982

4.  Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.

Authors:  Catherine Kubiak; Soma Jyonouchi; Caroline Kuo; Maria Garcia-Lloret; Morna J Dorsey; John Sleasman; Arthur S Zbrozek; Elena E Perez
Journal:  J Allergy Clin Immunol Pract       Date:  2014-08-28

Review 5.  Newborn screening for cystic fibrosis: a lesson in public health disparities.

Authors:  Lainie Friedman Ross
Journal:  J Pediatr       Date:  2008-09       Impact factor: 4.406

6.  Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier?

Authors:  Michelle Steinraths; Hilary D Vallance; A George F Davidson
Journal:  Can Fam Physician       Date:  2008-06       Impact factor: 3.275

7.  Is newborn screening for cystic fibrosis a basic human right?

Authors:  Philip M Farrell
Journal:  J Cyst Fibros       Date:  2008-02-11       Impact factor: 5.482

Review 8.  Newborn screening for cystic fibrosis.

Authors:  Kevin W Southern; Marieke M E Mérelle; Jeannette E Dankert-Roelse; A D Nagelkerke
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

9.  Sweat test practice in pediatric pulmonology after introduction of cystic fibrosis newborn screening.

Authors:  Céline Grimaldi; François Brémont; Michèle Berlioz-Baudoin; Jacques Brouard; Harriet Corvol; Laure Couderc; Guillaume Lezmi; Isabelle Pin; Isabelle Petit; Philippe Reix; Natacha Remus; Cyril Schweitzer; Caroline Thumerelle; Jean-Christophe Dubus
Journal:  Eur J Pediatr       Date:  2015-06-16       Impact factor: 3.183

10.  Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.

Authors:  Joseph F Levy; Marjorie A Rosenberg; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2016-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.